BEN COOKE: Open Payments
NPI 1528512803 · ATASCADERO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,003 in 60 payments from 10 companies in 2025. Trend: 2023 $1,935 · 2024 $1,212 · 2025 $1,003
Food & beverage: $1,003
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $203 |
| Novo Nordisk Inc | 14 | $184 |
| Bayer Healthcare Pharmaceuticals Inc. | 14 | $162 |
| GlaxoSmithKline, LLC. | 11 | $161 |
| ViiV Healthcare Company | 4 | $89 |
| GENZYME CORPORATION | 3 | $55 |
| PFIZER INC. | 2 | $54 |
| BIOTRONIK NRO, Inc. | 1 | $45 |
| Amgen Inc. | 2 | $34 |
| Exact Sciences Corporation | 1 | $17 |
Products named: Kerendia, TRELEGY ELLIPTA, QULIPTA, Ozempic, UBRELVY, APRETUDE, Wegovy, DUPIXENT.
Industry payments across CA — which companies pay providers there.
